Management Strategies for POSEIDON Groups 3 and 4.
ART calculator
Bologna criteria
POSEIDON criteria
blastocyst
controlled ovarian stimulation
poor ovarian response
pregnancy
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2019
2019
Historique:
received:
18
03
2019
accepted:
23
08
2019
entrez:
2
10
2019
pubmed:
2
10
2019
medline:
2
10
2019
Statut:
epublish
Résumé
In the POSEIDON classification, patients belonging to groups 3 and 4 share the same common feature of a poor ovarian reserve which independently of age renders them at high risk of a poor reproductive outcome. Overall, POSEIDON groups 1-4 constitute approximately 47% of patients attending assisted reproductive technology (ART) treatment. With the increasing delay in childbearing, POSEIDON group 4 seems to increase in numbers now in some centers constituting more than 50% of the total POSEIDON population, whereas group 3 patients constitute approximately 10%. Both POSEIDON groups 3 and 4 patients require special attention as regards pre-treatment strategy, ovarian stimulation, adjuvant treatment, and ovulation trigger strategy in order to optimize the probability of having at least one euploid blastocyst for transfer. Although more evidence is needed, recent advances seem to have increased the reproductive outcomes in the poor prognosis patient. The key to success is individualization in all steps of ART treatment. Herein, we review the recent evidence for the management of POSEIDON groups 3 and 4.
Identifiants
pubmed: 31572298
doi: 10.3389/fendo.2019.00614
pmc: PMC6749147
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
614Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
Copyright © 2019 Haahr, Dosouto, Alviggi, Esteves and Humaidan.
Références
Hum Reprod. 2018 Jun 15;:null
pubmed: 29912374
Fertil Steril. 2018 Jun;109(6):993-999
pubmed: 29935660
Fertil Steril. 2014 Jan;101(1):147-53
pubmed: 24188873
Cochrane Database Syst Rev. 2011 Feb 16;(2):CD005354
pubmed: 21328276
Hum Reprod. 2017 Dec 1;32(12):2496-2505
pubmed: 29121326
Hum Reprod. 2018 May 1;33(5):979-980
pubmed: 29596585
Hum Reprod. 2016 Feb;31(2):370-6
pubmed: 26724797
Hum Reprod. 2018 Oct 1;33(10):1875-1882
pubmed: 30137360
Cochrane Database Syst Rev. 2010 Jan 20;(1):CD000099
pubmed: 20091500
Reprod Biol Endocrinol. 2010 Sep 16;8:112
pubmed: 20846363
Reprod Biomed Online. 2019 Jun;38(6):908-915
pubmed: 30954433
Nat Med. 2012 Sep;18(9):1321
pubmed: 22961151
Fertil Steril. 2009 Dec;92(6):2082-4
pubmed: 19589522
Hum Reprod. 2017 Nov 1;32(11):2209-2217
pubmed: 29040519
Fertil Steril. 2011 Nov;96(5):1058-61.e7
pubmed: 22036048
Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13215-20
pubmed: 9371826
J Clin Endocrinol Metab. 1999 Aug;84(8):2951-6
pubmed: 10443703
Endocr Rev. 2018 Oct 1;39(5):549-592
pubmed: 29905829
Medicine (Baltimore). 2017 Mar;96(12):e6443
pubmed: 28328856
J Clin Endocrinol Metab. 1998 Jul;83(7):2479-85
pubmed: 9661631
Gynecol Endocrinol. 2015 Feb;31(2):145-7
pubmed: 25385007
Hum Reprod. 2007 Apr;22(4):980-8
pubmed: 17204525
Reprod Sci. 2018 Jul;25(7):980-982
pubmed: 27489169
Fertil Steril. 2010 Jul;94(2):662-5
pubmed: 19368912
Hum Reprod. 2005 May;20(5):1213-20
pubmed: 15760966
Front Endocrinol (Lausanne). 2017 Jun 07;8:116
pubmed: 28638367
Reprod Biol Endocrinol. 2018 Mar 27;16(1):29
pubmed: 29587861
Fertil Steril. 2008 Jun;89(6):1685-93
pubmed: 17681325
J Ovarian Res. 2014 Aug 02;7:77
pubmed: 25296696
J Clin Endocrinol Metab. 2002 Feb;87(2):709-15
pubmed: 11836309
J Assist Reprod Genet. 2017 Jun;34(6):749-758
pubmed: 28321529
Fertil Steril. 2018 Apr;109(4):644-664
pubmed: 29653717
Reprod Biomed Online. 2012 Nov;25(5):450-9
pubmed: 22999555
Hum Reprod. 2012 Dec;27(12):3481-6
pubmed: 22940767
Hum Reprod Update. 2009 Nov-Dec;15(6):613-22
pubmed: 19561136
Hum Reprod. 1997 Nov;12(11):2385-7
pubmed: 9436669
Reprod Biomed Online. 2013 Apr;26(4):378-83
pubmed: 23497915
J Assist Reprod Genet. 2017 Dec;34(12):1645-1651
pubmed: 28871409
Hum Reprod. 2017 Mar 1;32(3):544-555
pubmed: 28137754
J Clin Endocrinol Metab. 2012 Oct;97(10):E1987-94
pubmed: 22865900
Hum Reprod. 2018 May 1;33(5):982-983
pubmed: 29596626
Panminerva Med. 2019 Mar;61(1):3-10
pubmed: 29962186
J Endocrinol. 1990 Sep;126(3):R1-4
pubmed: 2120380
Reprod Biomed Online. 2011 Feb;22 Suppl 1:S23-31
pubmed: 21575846
Hum Reprod. 2005 Mar;20(3):611-5
pubmed: 15591079
Fertil Steril. 2004 Jun;81(6):1542-7
pubmed: 15193474
Lancet. 2007 Mar 3;369(9563):743-749
pubmed: 17336650
Hum Reprod. 2000 May;15(5):999-1002
pubmed: 10783341
Hum Reprod. 2018 May 1;33(5):984-988
pubmed: 29596576
Fertil Steril. 2007 Sep;88(3):616-21
pubmed: 17451691
Hum Reprod. 2017 Nov 1;32(11):2225-2233
pubmed: 29040589
F1000Res. 2016 Dec 23;5:2911
pubmed: 28232864
Panminerva Med. 2019 Mar;61(1):42-51
pubmed: 30674181
Reprod Biol Endocrinol. 2013 Sep 28;11:96
pubmed: 24074027
Reprod Biol Endocrinol. 2019 Feb 6;17(1):18
pubmed: 30728019
Endocrinology. 1999 Jun;140(6):2637-40
pubmed: 10342852
Reprod Biol Endocrinol. 2014 Feb 20;12:17
pubmed: 24555766
Front Endocrinol (Lausanne). 2018 Jun 14;9:317
pubmed: 29963011
Fertil Steril. 2014 Jan;101(1):105-11
pubmed: 24161646
Endocrinology. 2002 Oct;143(10):4104-12
pubmed: 12239122
Panminerva Med. 2019 Mar;61(1):24-29
pubmed: 30021418
Reprod Biomed Online. 2006 Feb;12(2):221-33
pubmed: 16478591
Fertil Steril. 2015 Nov;104(5):1145-52.e1-5
pubmed: 26297646
Swiss Med Wkly. 2015 Feb 06;145:w14087
pubmed: 25668217
Science. 2004 Jan 30;303(5658):682-4
pubmed: 14726596
Gynecol Endocrinol. 2019 Jul;35(7):628-630
pubmed: 30810400
J Assist Reprod Genet. 2017 Aug;34(8):1059-1066
pubmed: 28573524
PLoS One. 2018 Nov 7;13(11):e0207081
pubmed: 30403766
Cochrane Database Syst Rev. 2015 Nov 26;(11):CD009749
pubmed: 26608695
Fertil Steril. 2016 Jun;105(6):1452-3
pubmed: 26921622
Endocr Rev. 2011 Jun;32(3):356-86
pubmed: 21123740
Hum Reprod. 2019 Jan 01;34(1):171-180
pubmed: 30541039
Annu Rev Biochem. 1981;50:465-95
pubmed: 6267989
Reprod Biomed Online. 2019 May;38(5):677-682
pubmed: 30795977
J Clin Endocrinol Metab. 1990 Oct;71(4):918-22
pubmed: 2119392
Fertil Steril. 2012 Mar;97(3):561-71
pubmed: 22244781
Hum Reprod. 2011 Jul;26(7):1768-74
pubmed: 21558332
Hum Reprod. 2011 Oct;26(10):2742-9
pubmed: 21778283
Hum Reprod. 2008 Oct;23(10):2346-51
pubmed: 18583332
Front Endocrinol (Lausanne). 2019 Feb 28;10:99
pubmed: 30873117
Fertil Steril. 2017 Sep;108(3):532-538
pubmed: 28865552
Front Endocrinol (Lausanne). 2017 Jun 01;8:114
pubmed: 28620352
Fertil Steril. 2014 Jun;101(6):1624-8
pubmed: 24680364
Hum Reprod. 2012 May;27(5):1357-67
pubmed: 22357773
J Clin Invest. 1998 Jun 15;101(12):2622-9
pubmed: 9637695
Cochrane Database Syst Rev. 2010 Jan 20;(1):CD004379
pubmed: 20091563
Fertil Steril. 2008 Jul;90(1):231-3
pubmed: 17981269
Fertil Steril. 2011 Sep;96(3):590-3
pubmed: 21718992
Hum Reprod. 1998 Jun;13(6):1461-4
pubmed: 9688371
Hum Reprod. 2018 May 1;33(5):983-984
pubmed: 29596578
J Assist Reprod Genet. 2016 Aug;33(8):981-91
pubmed: 27094195
Fertil Steril. 2016 Jun;105(6):1488-1495.e1
pubmed: 27020168
Fertil Steril. 2014 Dec;102(6):1633-40.e5
pubmed: 25256937
Biol Reprod. 1999 Aug;61(2):353-7
pubmed: 10411511
Front Endocrinol (Lausanne). 2018 Oct 17;9:589
pubmed: 30386293
Hum Reprod Update. 2012 Mar-Apr;18(2):127-45
pubmed: 22307331
Hum Reprod. 2006 Dec;21(12):3217-27
pubmed: 16873892
J Clin Endocrinol Metab. 1989 Oct;69(4):716-24
pubmed: 2506212